Tumor markers - An update

被引：21

作者：

Pamies, RJ ^{[1
]}

Crawford, DR ^{[1
]}

机构：

[1] CASE WESTERN RESERVE UNIV,SCH MED,DEPT BIOCHEM,CLEVELAND,OH 44106

来源：

MEDICAL CLINICS OF NORTH AMERICA | 1996年 / 80卷 / 01期

关键词：

D O I：

10.1016/S0025-7125(05)70435-1

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Cancer remains the second leading cause of death in developed countries, and the incidence of certain tumors is increasing despite emphasis on prevention and screening. Tumor markers are biologic or biochemical substances that are produced by tumor cells and then secreted into the circulation in delectable amounts. This article covers some of the more common tumor markers currently being utilized for diagnostic and prognostic purposes.

引用

页码：185 / &

页数：16

共 88 条

[1]

ALBERS P, 1995, CANCER, V75, P844, DOI 10.1002/1097-0142(19950201)75:3<844::AID-CNCR2820750316>3.0.CO

[2]

2-C

[3]

AMMON A, 1993, CLIN INVESTIGATOR, V71, P434

[4]

ANDERSSON L, 1985, SCAND J CLIN LAB INV, V45, P107

[5]

AZIZ KJ, 1993, CLIN CHEM, V39, P2439

[6]

BAKER TS, 1994, ADV EXP MED BIOL, V353, P61

[7] CARCINOEMBRYONIC ANTIGEN IN STAGING AND FOLLOW-UP OF PATIENTS WITH SOLID TUMORS [J].

BALLESTA, AM ;

MOLINA, R ;

FILELLA, X ;

JO, J ;

GIMENEZ, N .

TUMOR BIOLOGY, 1995, 16 (01) :32-41

[8]

BAST RC, 1993, CLIN CHEM, V39, P2444

[9]

BAST RC, 1992, CANCER S, V60, P1984

[10] PROSTATE SPECIFIC ANTIGEN DENSITY - A MEANS OF DISTINGUISHING BENIGN PROSTATIC HYPERTROPHY AND PROSTATE-CANCER [J].

BENSON, MC ;

WHANG, IS ;

PANTUCK, A ;

RING, K ;

KAPLAN, SA ;

OLSSON, CA ;

COONER, WH .

JOURNAL OF UROLOGY, 1992, 147 (03) :815-816

← 1 2 3 4 5 6 7 8 9 →